Xu, Yuan
Miao, Junjie
Dai, Jianrong
Funding for this research was provided by:
the CAMS Innovation Fund for Medical Sciences (2023-I2M-C&T-B095)
National High Level Hospital Clinical Research Funding and Beijing Hope Run Special Fund of Cancer Foundation of China (No. LC2022B25)
the Cancer precision radiotherapy peaking program (2021-DF-002)
Article History
Received: 24 July 2025
Accepted: 19 October 2025
First Online: 11 November 2025
Declarations
:
: The retrospective study was in accordance with the Declaration of Helsinki, and was approved by the review board of Cancer Hospital, Chinese Academy of Medical Sciences. Human Ethics and Consent to Participate declarations: not applicable.
: All authors approved the publication of this manuscript.
: The authors declare no competing interests.